Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9225 |
High Similarity |
NPD6674 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8239 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8153 |
Intermediate Similarity |
NPD37 |
Approved |
0.8151 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.8129 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8113 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8113 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8113 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8067 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7905 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7905 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7843 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7829 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7829 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7811 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7805 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7785 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7785 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7764 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7738 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7719 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7719 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7703 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7692 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7687 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD7985 |
Registered |
0.7639 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7639 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7635 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7605 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7588 |
Intermediate Similarity |
NPD7472 |
Approved |
0.755 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7533 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD4626 |
Approved |
0.75 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7467 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7459 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7457 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7452 |
Intermediate Similarity |
NPD7982 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7439 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7431 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7417 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7412 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7399 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7399 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7386 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7386 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7381 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7379 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7379 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7378 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7371 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7343 |
Intermediate Similarity |
NPD7340 |
Approved |
0.7342 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7342 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7341 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7337 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7321 |
Intermediate Similarity |
NPD4666 |
Phase 3 |
0.7318 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7297 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7292 |
Intermediate Similarity |
NPD7644 |
Approved |
0.7285 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7279 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD5709 |
Phase 3 |
0.725 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7248 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7248 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7244 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7237 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7233 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7229 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7225 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7197 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7197 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7195 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7192 |
Intermediate Similarity |
NPD1357 |
Approved |
0.719 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7151 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7151 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7151 |
Intermediate Similarity |
NPD27 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7133 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7133 |
Intermediate Similarity |
NPD1398 |
Phase 1 |
0.7133 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7126 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7125 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7119 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7119 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7119 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7119 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7117 |
Intermediate Similarity |
NPD2675 |
Approved |
0.7117 |
Intermediate Similarity |
NPD2676 |
Approved |
0.7113 |
Intermediate Similarity |
NPD228 |
Approved |
0.7101 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7093 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7093 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7079 |
Intermediate Similarity |
NPD7309 |
Approved |
0.707 |
Intermediate Similarity |
NPD4538 |
Approved |
0.707 |
Intermediate Similarity |
NPD4536 |
Approved |
0.707 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7067 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7055 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7055 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7052 |
Intermediate Similarity |
NPD4481 |
Phase 3 |
0.7045 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7035 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7035 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7034 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7034 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7032 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7027 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7024 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7024 |
Intermediate Similarity |
NPD5929 |
Approved |
0.7024 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.6993 |
Remote Similarity |
NPD5736 |
Approved |
0.6982 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.698 |
Remote Similarity |
NPD3496 |
Discontinued |
0.6977 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6975 |
Remote Similarity |
NPD2677 |
Approved |
0.6974 |
Remote Similarity |
NPD3094 |
Phase 2 |
0.6968 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6961 |
Remote Similarity |
NPD7906 |
Approved |
0.6951 |
Remote Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.6946 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6944 |
Remote Similarity |
NPD7843 |
Approved |
0.6943 |
Remote Similarity |
NPD3657 |
Discovery |
0.6943 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6943 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6936 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6933 |
Remote Similarity |
NPD1281 |
Approved |
0.6931 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6928 |
Remote Similarity |
NPD3686 |
Approved |
0.6928 |
Remote Similarity |
NPD3687 |
Approved |
0.6927 |
Remote Similarity |
NPD4578 |
Approved |
0.6927 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6927 |
Remote Similarity |
NPD4577 |
Approved |
0.6923 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD5494 |
Approved |
0.6918 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6918 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.6918 |
Remote Similarity |
NPD5588 |
Approved |
0.6914 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6909 |
Remote Similarity |
NPD6273 |
Approved |
0.6901 |
Remote Similarity |
NPD2684 |
Approved |
0.6899 |
Remote Similarity |
NPD6353 |
Approved |
0.6899 |
Remote Similarity |
NPD4097 |
Suspended |
0.689 |
Remote Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD7041 |
Phase 2 |
0.6886 |
Remote Similarity |
NPD3226 |
Approved |
0.6875 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6875 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6875
|
Remote Similarity |
NPD4476 |
Approved |